Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The role of cholinergic integrity on cognitive impairment in Parkinson’s disease

FY 2021-22

Summary
Although Parkinsons Disease (PD) is typically characterized as a motor disorder, most patients also experience cognitive symptoms from the earliest stages of the disease. Despite the belief that PD is caused by a loss of dopamine-producing brain cells, PD symptoms are not fully alleviated by dopamine-replacement. Interestingly, while acetylcholine-producing (cholinergic) brain cells also decay in PD, researchers have generally assumed that their degeneration only occurs in later disease stages, causing dementia symptoms. As a result, acetylcholine replacements have only been provided to patients with advanced stage PD. Recent evidence suggests, however, that the loss of cholinergic brain cells occur early in disease progression; explaining why some cognitive symptoms (e.g., reduced concentration) also occur early on. The primary objective of this project is to determine whether cholinergic degeneration in early PD is associated with changes in cognitive function. Our second objective is to examine whether the loss of structural connections between the deep cholinergic regions and the rest of the brain are associated with attentional deficits. In this study, we will use cognitive tests to assess for the presence of cognitive dysfunction in PD patients and magnetic resonance imaging (MRI) brain scans to measure the loss of cholinergic brain cells and their connections across the brain. We predict that cholinergic degeneration will be associated with cognitive dysfunction in the earlier stages of the disease, long before the onset of dementia. The results of this study will help us to better understand the cognitive symptoms in PD patients and will provide new clues about how to treat them.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466762
Name
Bailey Alexander
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of cholinergic integrity on cognitive impairment in Parkinson’s disease
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Basal Forebrain; Cholinergic Pathways; Cognition; Cognitive Dysfunction; Diffusion-Weighted Magnetic Resonance Imaging; Microstructural Integrity; Nucleus Basalis Of Meynert; Parkinson'S Disease; Structural Connectivity; White Matter
Abstract
Although Parkinsons Disease (PD) is typically characterized as a motor disorder, most patients also experience cognitive symptoms from the earliest stages of the disease. Despite the belief that PD is caused by a loss of dopamine-producing brain cells, PD symptoms are not fully alleviated by dopamine-replacement. Interestingly, while acetylcholine-producing (cholinergic) brain cells also decay in PD, researchers have generally assumed that their degeneration only occurs in later disease stages, causing dementia symptoms. As a result, acetylcholine replacements have only been provided to patients with advanced stage PD. Recent evidence suggests, however, that the loss of cholinergic brain cells occur early in disease progression; explaining why some cognitive symptoms (e.g., reduced concentration) also occur early on. The primary objective of this project is to determine whether cholinergic degeneration in early PD is associated with changes in cognitive function. Our second objective is to examine whether the loss of structural connections between the deep cholinergic regions and the rest of the brain are associated with attentional deficits. In this study, we will use cognitive tests to assess for the presence of cognitive dysfunction in PD patients and magnetic resonance imaging (MRI) brain scans to measure the loss of cholinergic brain cells and their connections across the brain. We predict that cholinergic degeneration will be associated with cognitive dysfunction in the earlier stages of the disease, long before the onset of dementia. The results of this study will help us to better understand the cognitive symptoms in PD patients and will provide new clues about how to treat them.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bailey, Alexander
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~